WebThe Investor Relations website contains information about Black Diamond Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. WebJan 5, 2024 · About Black Diamond Black Diamond Therapeutics is a clinical-stage precision oncology medicine company focused on the development of MasterKey therapies that target families of oncogenic mutations in clinically validated targets. ... Stern Investor Relations (212) 362-1200 [email protected] [email protected]. Site - Shareholder …
Black Diamond Therapeutics Reports Fourth Quarter and Full …
WebBlack Diamond Therapeutics. 6,657 followers. 6mo. Black Diamond is pleased to announce the appointment of Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer. Dr. Yurasov brings over 25 years of ... WebFeb 27, 2024 · The Company’s proprietary Mutation-Allostery-Pharmacology, or MAP drug discovery engine, is designed to allow Black Diamond to analyze population-level genetic sequencing tumor data and validate ... skyward huntington middle school
Investor Relations • Black Diamond Therapeutics
WebFeb 11, 2024 · A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks. About Black Diamond Therapeutics WebBlack Diamond Therapeutics . About. Our Vision; Leadership; Board of Directors; Our Platform. ... Life at Black Diamond. Values; Careers; ... Media Inquiries: [email protected]. General: [email protected]. Investor Relations: [email protected]. Follow us LinkedIn. Join our team of experts working at the forefront of precision oncology medicines. ... WebSep 12, 2024 · Sep 12, 2024, 08:17 ET. CAMBRIDGE, Mass., Sept. 12, 2024 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development … swedish fmla